229000.KQ | Gencurix Inc. Annual & Quarterly Balance

Annual Balance Sheets

(In KRW)

Breakdown	2023	2022	2021	2020	2019	2018
Total Assets	33.5 Billion	37.23 Billion	55.28 Billion	63.97 Billion	2.38 Billion	10.38 Billion
Total Current Assets	13.64 Billion	8.01 Billion	23.54 Billion	11.13 Billion	1.1 Billion	7.96 Billion
Cash And Short Term Investments	11.26 Billion	5.85 Billion	21.96 Billion	5.62 Billion	561.93 Million	7.22 Billion
Cash and Cash Equivalents	2.92 Billion	5.85 Billion	11.96 Billion	5.62 Billion	561.93 Million	7.22 Billion
Short Term Investments	8.34 Billion	103.44 Million	10 Billion	-	31.8 Million	-
Net Receivables	1.42 Billion	1.02 Billion	871.07 Million	853.63 Million	159.11 Million	373.49 Million
Inventory	581.02 Million	866.06 Million	460.22 Million	4.37 Billion	208.81 Million	34.43 Million
Other Current Assets	369.97 Million	257.96 Million	253.3 Million	275.05 Million	177.19 Million	326.89 Million
Total Non-Current Assets	19.85 Billion	29.22 Billion	31.73 Billion	52.84 Billion	1.28 Billion	2.42 Billion
Net PPE	13.91 Billion	13.99 Billion	1.76 Billion	1.39 Billion	-	1.16 Billion
Good Will And Intangible Assets	747.55 Million	535.63 Million	3.73 Billion	3.22 Billion	-	-
Good Will	-	-	3.19 Billion	3.19 Billion	-	-
Intangible Assets	747.55 Million	535.63 Million	545.68 Million	38.2 Million	-	-
Long-Term Investments	5.18 Billion	14.69 Billion	26.23 Billion	48.21 Billion	1.28 Billion	437.17 Million
Tax Assets	-927.77 Million	28.95 Billion	30.25 Billion	52.03 Billion	-	-
Other Non Current Assets	927.77 Million	-28.95 Billion	-30.25 Billion	-52.03 Billion	-	819.39 Million
Other Assets	-	1.00	-	-	-	-
Total Liabilities	21.49 Billion	31.56 Billion	24.24 Billion	10.06 Billion	2.23 Billion	1.25 Billion
Total Current Liabilities	15.66 Billion	25.86 Billion	23.19 Billion	8.57 Billion	1.79 Billion	1.25 Billion
Account Payables	34.95 Million	52.94 Million	18.68 Million	96.74 Million	105.04 Million	24.99 Million
Tax Payables	-	-	-	-	-	-
Short Term Debt	12.21 Billion	4.23 Billion	377.1 Million	1.23 Billion	778.62 Million	550 Million
Deferred Revenue	319.53 Million	294.53 Million	294.53 Million	305.87 Million	64.35 Million	45.06 Million
Other Current Liabilities	3.09 Billion	21.28 Billion	22.5 Billion	6.93 Billion	843.59 Million	638.71 Million
Total Non Current Liabilities	5.83 Billion	5.69 Billion	1.04 Billion	1.49 Billion	440.72 Million	-
Long-Term Debt	5.47 Billion	3.85 Billion	237.91 Million	128.66 Million	309.41 Million	-
Deferred Revenue Non Current	-	-	6.00	474.66 Million	-	-
Deferred Tax Liabilities Non Current	-	-	-	-	-	-
Other Non Current Liabilities	355 Million	1.84 Billion	810.28 Million	889.42 Million	131.31 Million	-
Other Liabilities	-	-	-	1.00	1.00	-
Total Equity	12 Billion	5.67 Billion	31.04 Billion	53.91 Billion	155.18 Million	9.12 Billion
Stock Holders Equity	13.77 Billion	6.47 Billion	30.99 Billion	53.37 Billion	155.18 Million	9.12 Billion
Common Stock	6.78 Billion	3.33 Billion	3.27 Billion	3.19 Billion	2.69 Billion	2.69 Billion
Retained Earnings	-85.21 Billion	-66.04 Billion	-40.21 Billion	-5.54 Billion	-38.65 Billion	-29.49 Billion
Accumulated other comprehensive income	2.78 Billion	1.43 Billion	1.32 Billion	1.37 Billion	2.22 Billion	2.44 Billion
Common Stock Equity	13.77 Billion	6.47 Billion	30.99 Billion	53.37 Billion	155.18 Million	9.12 Billion
Capital Lease Obligation	259.16 Million	149.02 Million	237.91 Million	474.66 Million	309.41 Million	-
Total Investments	13.52 Billion	14.69 Billion	36.23 Billion	48.21 Billion	1.28 Billion	437.17 Million
Total Debt	17.95 Billion	8.23 Billion	615.02 Million	1.84 Billion	1.08 Billion	550 Million
Net Debt	15.02 Billion	2.37 Billion	-11.34 Billion	-3.78 Billion	526.1 Million	-6.67 Billion

Breakdown	2024 Q2	2024 Q1	2023 FY	2023 Q4	2023 Q3	2023 Q2
Total Assets	23.94 Billion	33.12 Billion	33.5 Billion	33.5 Billion	34.64 Billion	36.96 Billion
Total Current Assets	2.86 Billion	11.13 Billion	13.64 Billion	13.64 Billion	9.93 Billion	12.43 Billion
Cash And Short Term Investments	773.79 Million	8.6 Billion	11.26 Billion	11.26 Billion	7.31 Billion	10.53 Billion
Cash and Cash Equivalents	770.64 Million	1.09 Billion	2.92 Billion	2.92 Billion	4.31 Billion	4.03 Billion
Short Term Investments	3.14 Million	7.51 Billion	8.34 Billion	8.34 Billion	3 Billion	6.5 Billion
Net Receivables	1.34 Billion	1.57 Billion	1.42 Billion	1.42 Billion	1.58 Billion	886.17 Million
Inventory	515.44 Million	617.74 Million	581.02 Million	581.02 Million	789.56 Million	895.59 Million
Other Current Assets	229.62 Million	332.65 Million	369.97 Million	369.97 Million	247.18 Million	115.53 Million
Total Non-Current Assets	21.08 Billion	21.99 Billion	19.85 Billion	19.85 Billion	24.71 Billion	24.53 Billion
Net PPE	13.56 Billion	13.9 Billion	13.91 Billion	13.91 Billion	14.74 Billion	13.52 Billion
Good Will And Intangible Assets	749.54 Million	743.19 Million	747.55 Million	747.55 Million	729.22 Million	690.81 Million
Good Will	-	-	-	-	-	-
Intangible Assets	749.54 Million	743.19 Million	747.55 Million	747.55 Million	729.22 Million	690.81 Million
Long-Term Investments	6.77 Billion	7.34 Billion	5.18 Billion	5.18 Billion	9.23 Billion	10.31 Billion
Tax Assets	6.00	-743.19 Million	-927.77 Million	-927.77 Million	24.45 Billion	24.21 Billion
Other Non Current Assets	-10.00	743.19 Million	927.77 Million	927.77 Million	-24.45 Billion	-24.21 Billion
Other Assets	-	-	-	-	-	-
Total Liabilities	15.37 Billion	20.95 Billion	21.49 Billion	21.49 Billion	20.39 Billion	18.99 Billion
Total Current Liabilities	12.91 Billion	15.07 Billion	15.66 Billion	15.66 Billion	13.43 Billion	13.17 Billion
Account Payables	16.7 Million	8.21 Million	34.95 Million	34.95 Million	71.76 Million	22.16 Million
Tax Payables	-	-	-	-	-	-
Short Term Debt	8.4 Billion	11.2 Billion	12.21 Billion	12.21 Billion	11.9 Billion	11.85 Billion
Deferred Revenue	294.53 Million	402.4 Million	319.53 Million	319.53 Million	319.53 Million	364.39 Million
Other Current Liabilities	4.19 Billion	3.45 Billion	3.09 Billion	3.09 Billion	1.13 Billion	933.58 Million
Total Non Current Liabilities	2.45 Billion	5.88 Billion	5.83 Billion	5.83 Billion	6.95 Billion	5.81 Billion
Long-Term Debt	2.28 Billion	5.72 Billion	5.47 Billion	5.47 Billion	4.97 Billion	3.85 Billion
Deferred Revenue Non Current	-	-	-	-	-	-
Deferred Tax Liabilities Non Current	-	-	-	-	-	-
Other Non Current Liabilities	168.65 Million	161.39 Million	355 Million	355 Million	1.98 Billion	1.96 Billion
Other Liabilities	-	1.00	-	-	-	1.00
Total Equity	8.57 Billion	12.16 Billion	12 Billion	12 Billion	14.25 Billion	17.97 Billion
Stock Holders Equity	10.59 Billion	14.12 Billion	13.77 Billion	13.77 Billion	15.71 Billion	19.26 Billion
Common Stock	7.22 Billion	7.2 Billion	6.78 Billion	6.78 Billion	6.65 Billion	6.62 Billion
Retained Earnings	-92.5 Billion	-88.44 Billion	-85.21 Billion	-85.21 Billion	-81.82 Billion	-78.25 Billion
Accumulated other comprehensive income	2.55 Billion	2.02 Billion	2.78 Billion	2.78 Billion	1.45 Billion	1.43 Billion
Common Stock Equity	10.59 Billion	14.12 Billion	13.77 Billion	13.77 Billion	15.71 Billion	19.26 Billion
Capital Lease Obligation	52.02 Million	60.15 Million	259.16 Million	259.16 Million	9.49 Million	40.13 Million
Total Investments	6.77 Billion	14.86 Billion	13.52 Billion	13.52 Billion	12.23 Billion	16.81 Billion
Total Debt	10.74 Billion	16.99 Billion	17.95 Billion	17.95 Billion	16.88 Billion	15.74 Billion
Net Debt	9.97 Billion	15.9 Billion	15.02 Billion	15.02 Billion	12.56 Billion	11.7 Billion

Balance Sheet Charts

Penyao Environmental Protection Co., Ltd.

300664

Full Analysis

Annual Balance Sheets
BaTelab Co Ltd

2149

Full Analysis

Annual Balance Sheets
Everest Organics Limited

EVERESTO

Full Analysis

Annual Balance Sheets
NDT Pharmaceuticals Inc.

NDTP

Full Analysis

Annual Balance Sheets
INTLOOP Inc.

9556

Full Analysis

Annual Balance Sheets
AstraZeneca PLC

AZN

Full Analysis

Annual Balance Sheets

Global Stocks Search

Gencurix Inc. (229000.KQ)

Annual Balance Sheets

Balance Sheet Charts

Penyao Environmental Protection Co., Ltd.

BaTelab Co Ltd

Everest Organics Limited

NDT Pharmaceuticals Inc.

INTLOOP Inc.

AstraZeneca PLC